Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock [Yahoo! Finance]
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock
Soleno Therapeutics Announces Proposed Public Offering of Common Stock
Soleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi Syndrome [Yahoo! Finance]
Soleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi Syndrome